Pharmaceutical Company Drives New Levels of Data Acceptability

What do you do when there are large discrepancies in your data? Download this case study to learn how a leading global pharmaceutical company overcame this challenge.

You’ll gain insight into how a new study design that leveraged ERT Respiratory solutions and Portfolio Business Intelligence was the key to success – improving statistical outcomes and reducing site data quality issues. You’ll learn how ERT:

  • Generated higher-quality data for regulatory submission
  • Drove data acceptability to 95%+
  • Achieved database lock on schedule, and more!

By submitting this form you are consenting to receive digital communications from ERT and you agree to our Privacy Policy and Website Terms of Use.